Mersana Therapeutics
- World
Synaffix Wins Best Platform Technology at 7th Annual World ADC Awards
Amsterdam, Netherlands: Synaffix B.V., a biotechnology company enabling antibody-drug conjugates (ADCs) with best-in-class therapeutic index, announces that it has won…
Read More »